Trial Profile
Androgen effects in HIV-infected women.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Female testosterone deficiency
- Focus Pharmacodynamics
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2010 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 15 May 2009 Primary endpoint 'Mass of lean tissue' has been met.